LINK Medical has announced the opening of its new UK office at MedCity, in London’s City region.
The expansion to London will enable the company to bring significant value to UK-based biopharma and medtech companies by accelerating their product development, they state in their press release.
The MedCity location was strategically chosen for its world-leading life sciences cluster that supports life sciences investment, entrepreneurship, and expertise.
“We look forward to start building on the competent team already present in the UK to further engage with this important market. We can now offer our customers enhanced service capacity in the UK, helping to drive forward their clinical projects, and thus supporting and improving healthcare for all,” says LINK Medical CEO, Ola Gudmundsen.